BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17203810)

  • 1. [C-reactive protein in cardiovascular diseases].
    Lubas W; Gutkowski K
    Przegl Lek; 2006; 63(7):562-6. PubMed ID: 17203810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammatory markers and cytokines in cardiovascular disease].
    Ogiwara F; Takahashi M; Ikeda U
    Rinsho Byori; 2004 Aug; 52(8):686-92. PubMed ID: 15478624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations?
    Sattar N; Lowe GD
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):252-6. PubMed ID: 16824274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein: a new golden marker of cardiovascular risk.
    Gomes MC
    Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 8. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
    Yeh ET
    Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of CRP in coronary risk determination.
    Mehta JL; Sukhija R; Romeo F; Sepulveda JL
    Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-reactive protein potential risk factor for cardiovascular disease].
    Tornvall P; Pernow J; Hansson LO
    Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of inflammation and cardiovascular disease: clinical applications of C-reactive protein determination.
    Martínez VB; González-Juanatey JR
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():3-7. PubMed ID: 20000881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [C-reactive protein in cardiovascular risk evaluation].
    Fabijanić D; Banić M; Kardum D
    Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [C-reactive protein: cardiovascular issues of an acute-phase protein].
    Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R
    Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
    Wilson AM; Ryan MC; Boyle AJ
    Int J Cardiol; 2006 Jan; 106(3):291-7. PubMed ID: 16337036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.
    Hage FG; Szalai AJ
    J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein. Should it be considered a coronary risk factor?
    Aronow WS
    Geriatrics; 2003 May; 58(5):19-22, 25. PubMed ID: 12756677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
    Corson MA; Jones PH; Davidson MH
    Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atherosclerosis and inflammation: the role of C-reactive protein].
    Ablij HC; Meinders AE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):15-20. PubMed ID: 12564292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.